SCHEMBL10153508

SCHEMBL10153508

CC(C)(c1cc2c3ccccc3n3c4ccccc4c(c1)c23)C(C)(C)c1cc2c3ccccc3n3c4ccccc4c(c1)c23

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.40
KIF11 P52732 2/20 0.39
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
MEN1 O00255 3/20 0.36
MAPT P10636 3/20 0.36
KMT2A Q03164 3/20 0.36
POLB P06746 2/20 0.36
HTT P42858 2/20 0.36
ALKBH5 Q6P6C2 1/20 0.35
FTO Q9C0B1 1/20 0.35
HSD17B10 Q99714 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RCE1 Q9Y256 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
PTPN1 P18031 2/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717848 0.89 KIF11 (0.41) GPR3KIF11KDM4EALDH1A1HPGD
SCHEMBL10153492 0.89 GPR3 (0.40) GPR3KIF11KDM4EALDH1A1HPGD
SCHEMBL20858005 0.84 KIF11 (0.45) GPR3KIF11KDM4EALDH1A1HPGD
SCHEMBL20689987 0.80 KIF11 (0.45) GPR3KIF11KDM4EALDH1A1HPGD
SCHEMBL20689902 0.80 PGR (0.35) GPR3KIF11KDM4EALDH1A1HPGD
SCHEMBL21718004 0.80 KIF11 (0.38) GPR3KIF11KDM4EALDH1A1HPGD
SCHEMBL25490492 0.79 KIF11 (0.36) GPR3KIF11KDM4EALDH1A1HPGD
SCHEMBL26760307 0.79 KIF11 (0.41) GPR3KIF11KDM4EALDH1A1HPGD
SCHEMBL10153558 0.78 GPR3 (0.44) GPR3KDM4EALDH1A1HPGDMEN1
SCHEMBL21717860 0.78 KIF11 (0.38) GPR3KIF11KDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-12 US disclosed
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-12 US disclosed
US-8174002-B2 Organic electroluminescence device FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-8174002-B2 Organic electroluminescence device FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 GPR3 2926/4885KIF11 408/4885KDM4E 2229/4885
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 GPR3 2926/4885KIF11 408/4885KDM4E 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.